USC cardiology chief Saxon: 'People are using their phones for everything except their own health. We aim to change that.'

July 16, 2012 by Sony Salzman

MassDevice discusses medical devices for mobile phones and the future of networked patient care with Dr. Leslie Saxon, cardiology chief at the University of Southern California.

MassDevice.com news

As cardiology chief of the Keck School of Medicine at the University of Southern California, Dr. Leslie Saxon is spearheading a successful mobile health innovation center called the Center for Body Computing. Founded in 2010, the coalition works with engineers, device companies and thought leaders to develop mobile health software and apps.

Saxon's ultimate goal is to create a single platform that is the "epicenter of wireless health." The CBC has developed working relationships with device companies and innovators including Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX) and St. Jude Medical (NYSE:STJ). She also hosts an annual Body Computing Conference, which brings together cross-disciplinary leaders from medicine, design, gaming and pharmaceuticals.

Sign up to get our free newsletters delivered straight to your inbox

The goal of all this collaboration is a “Facebook for healthcare," where patients, doctors and manufacturers share data in a dynamic online space. With more than 5 billion people wielding mobile devices, Saxon believes it's time to re-think the way healthcare is consumed. MassDevice.com caught up with Saxon to discuss her vision for the future of mHealth.

MassDevice: How does the Center for Body Computing find fresh new ideas to develop?

Comments

Features

Animal rights advocacy group PETA holds a tiny stake in several medtech companies, taking frequent advantage of its shareholder rights to push changes in the way device makers experiment on animals.

AliveCor's interim-ish CEO Euan Thomson talks about the data-driven future, why he jumped ship at Accuray and how to navigate the intersection between the tempered medical device world and the wanton nimbleness of Silicon Valley.

Medtronic executive Dr. Stephen Oesterle thinks Google will be a force to be reckoned with in the medical technology space in coming years.

Roger Pontz, 1 of the first recipients of Second Sight Medical's Argus II 'bionic eye,' tells MassDevice.com about how it's changed his life.

Definiens CEO Thomas Heydler discusses his ambition to position his company at the forefront of the coming revolution in personalized and predictive medicines.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp